Skip to Main Content

The press release, issued earlier this year, announced a partnership that surely raised a few eyebrows. The International AIDS Vaccine Initiative would be working with a coalition on epidemic preparedness to develop a Lassa fever vaccine.

Then, earlier this month, IAVI, as the HIV vaccine group is known, announced it would absorb the operations of an organization founded to spur development of better tuberculosis vaccines.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Comments are closed.